Early commercialization pattern profiling: Nano-enhanced biosensors

Recently, nano-enhanced biosensors (NBS) have attracted considerable attention. Not only their R&D status, but also their commercialization potentials, hold appeal for corporations and government policy makers. We are studying company involvement in NBS R&D through publication and patent records to capture the early commercialization patterns. On the one hand, we compare the leading countries in profiling the cluster of commercial activities. We also explore future prospects by positing multiple innovation pathways for NBS. These help to elucidate promising targets, key players, pivotal technology developments on a critical path, and impediments. Taken together, these Future-Oriented Technology Analyses empower the management of emerging technologies.